Testing effectiveness (Phase 2)Study completedNCT00000842
What this trial is testing
A Phase II, Double-Blind Trial of Recombinant Human Nerve Growth Factor for Treatment of HIV-Associated Sensory Neuropathy
Who this might be right for
HIV InfectionsPeripheral Nervous System Disease
National Institute of Allergy and Infectious Diseases (NIAID) 270